Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation

Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-06, Vol.10 (13), p.2860
Main Authors: Yamamoto, Akitaka, Wada, Hideo, Ichkawa, Yuhuko, Tanaka, Motoko, Tashiro, Haruhiko, Shiraki, Katsuya, Shimpo, Hideto, Yamashita, Yoshiki, Mastumoto, Takeshi, Shimaoka, Motomu, Iba, Toshiaki, Suzuki-Inoue, Katsue
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Aortic aneurysms
Biomarkers
Blood platelets
Cancer therapies
Clinical medicine
Disease
Hypothermia
Infections
Laboratories
Monoclonal antibodies
Obstetrics
Patients
Plasma
Thrombosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3
cites cdi_FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3
container_end_page
container_issue 13
container_start_page 2860
container_title Journal of clinical medicine
container_volume 10
creator Yamamoto, Akitaka
Wada, Hideo
Ichkawa, Yuhuko
Tanaka, Motoko
Tashiro, Haruhiko
Shiraki, Katsuya
Shimpo, Hideto
Yamashita, Yoshiki
Mastumoto, Takeshi
Shimaoka, Motomu
Iba, Toshiaki
Suzuki-Inoue, Katsue
description Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC in critically ill patients. Plasma levels of sCLEC-2 and D-dimer were measured using the STACIA system. Plasma sCLEC-2 and D-dimer levels were significantly higher in patients with underlying diseases of DIC than in those with unidentified clinical syndrome (UCS). Plasma sCLEC-2 levels were significantly higher in the patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. Similarly, plasma D-dimer levels were also significantly higher in patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. The plasma sCLEC-2 levels in all patients and those with a DIC score ≤ 4 were significantly higher in non-survivors than survivors. The plasma D-dimer levels in all patients, those with a DIC score ≥ 5 and those with a DIC score ≤ 4, were significantly higher in non-survivors than in survivors. The plasma sCLEC-2 is expected as a marker for DIC/Pre-DIC as well as the prognostic marker in critically ill patients.
doi_str_mv 10.3390/jcm10132860
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8269023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2549395741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3</originalsourceid><addsrcrecordid>eNpdkU9rFEEQxRtRTIg5-QUavAgypvrfTvdF0I2ahQVB47mp6amNvZmZXrtnAvn29pIg0brUo-rH4xXF2GsB75VycLEPowChpF3BM3YqoW0bUFY9f6JP2Hkpe6hlrZaifclOlJagpIBT5n-kYekG4uvm-v5AfEthjlOzjbfEv1Ogw5wyl3xTOPJPMY2YbynzXR1exlJojBPO1PPNNGe8wxKWATNfJ7ypYo5pesVe7HAodP7Yz9jPL5-v11fN9tvXzfrjtgnayLlRocXOdVpD64ztWoPkVlDTGsJO95ZCb1bGohOyl1WBdQFEpxGwN5JQnbEPD76HpRupD3QMNPhDjjXyvU8Y_b-bKf7yN-nOW7lyIFU1ePtokNPvhcrsx1gCDQNOlJbipdFWC23AVfTNf-g-LXmq5x0pp5xptajUuwcq5FRKpt3fMAL88Xf-ye_UH5XyiiQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549395741</pqid></control><display><type>article</type><title>Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Yamamoto, Akitaka ; Wada, Hideo ; Ichkawa, Yuhuko ; Tanaka, Motoko ; Tashiro, Haruhiko ; Shiraki, Katsuya ; Shimpo, Hideto ; Yamashita, Yoshiki ; Mastumoto, Takeshi ; Shimaoka, Motomu ; Iba, Toshiaki ; Suzuki-Inoue, Katsue</creator><creatorcontrib>Yamamoto, Akitaka ; Wada, Hideo ; Ichkawa, Yuhuko ; Tanaka, Motoko ; Tashiro, Haruhiko ; Shiraki, Katsuya ; Shimpo, Hideto ; Yamashita, Yoshiki ; Mastumoto, Takeshi ; Shimaoka, Motomu ; Iba, Toshiaki ; Suzuki-Inoue, Katsue</creatorcontrib><description>Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC in critically ill patients. Plasma levels of sCLEC-2 and D-dimer were measured using the STACIA system. Plasma sCLEC-2 and D-dimer levels were significantly higher in patients with underlying diseases of DIC than in those with unidentified clinical syndrome (UCS). Plasma sCLEC-2 levels were significantly higher in the patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. Similarly, plasma D-dimer levels were also significantly higher in patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. The plasma sCLEC-2 levels in all patients and those with a DIC score ≤ 4 were significantly higher in non-survivors than survivors. The plasma D-dimer levels in all patients, those with a DIC score ≥ 5 and those with a DIC score ≤ 4, were significantly higher in non-survivors than in survivors. The plasma sCLEC-2 is expected as a marker for DIC/Pre-DIC as well as the prognostic marker in critically ill patients.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10132860</identifier><identifier>PMID: 34203210</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Acute coronary syndromes ; Aortic aneurysms ; Biomarkers ; Blood platelets ; Cancer therapies ; Clinical medicine ; Disease ; Hypothermia ; Infections ; Laboratories ; Monoclonal antibodies ; Obstetrics ; Patients ; Plasma ; Thrombosis</subject><ispartof>Journal of clinical medicine, 2021-06, Vol.10 (13), p.2860</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3</citedby><cites>FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3</cites><orcidid>0000-0001-9021-8633 ; 0000-0002-0255-4088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2549395741/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2549395741?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids></links><search><creatorcontrib>Yamamoto, Akitaka</creatorcontrib><creatorcontrib>Wada, Hideo</creatorcontrib><creatorcontrib>Ichkawa, Yuhuko</creatorcontrib><creatorcontrib>Tanaka, Motoko</creatorcontrib><creatorcontrib>Tashiro, Haruhiko</creatorcontrib><creatorcontrib>Shiraki, Katsuya</creatorcontrib><creatorcontrib>Shimpo, Hideto</creatorcontrib><creatorcontrib>Yamashita, Yoshiki</creatorcontrib><creatorcontrib>Mastumoto, Takeshi</creatorcontrib><creatorcontrib>Shimaoka, Motomu</creatorcontrib><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Suzuki-Inoue, Katsue</creatorcontrib><title>Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation</title><title>Journal of clinical medicine</title><description>Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC in critically ill patients. Plasma levels of sCLEC-2 and D-dimer were measured using the STACIA system. Plasma sCLEC-2 and D-dimer levels were significantly higher in patients with underlying diseases of DIC than in those with unidentified clinical syndrome (UCS). Plasma sCLEC-2 levels were significantly higher in the patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. Similarly, plasma D-dimer levels were also significantly higher in patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. The plasma sCLEC-2 levels in all patients and those with a DIC score ≤ 4 were significantly higher in non-survivors than survivors. The plasma D-dimer levels in all patients, those with a DIC score ≥ 5 and those with a DIC score ≤ 4, were significantly higher in non-survivors than in survivors. The plasma sCLEC-2 is expected as a marker for DIC/Pre-DIC as well as the prognostic marker in critically ill patients.</description><subject>Acute coronary syndromes</subject><subject>Aortic aneurysms</subject><subject>Biomarkers</subject><subject>Blood platelets</subject><subject>Cancer therapies</subject><subject>Clinical medicine</subject><subject>Disease</subject><subject>Hypothermia</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Monoclonal antibodies</subject><subject>Obstetrics</subject><subject>Patients</subject><subject>Plasma</subject><subject>Thrombosis</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkU9rFEEQxRtRTIg5-QUavAgypvrfTvdF0I2ahQVB47mp6amNvZmZXrtnAvn29pIg0brUo-rH4xXF2GsB75VycLEPowChpF3BM3YqoW0bUFY9f6JP2Hkpe6hlrZaifclOlJagpIBT5n-kYekG4uvm-v5AfEthjlOzjbfEv1Ogw5wyl3xTOPJPMY2YbynzXR1exlJojBPO1PPNNGe8wxKWATNfJ7ypYo5pesVe7HAodP7Yz9jPL5-v11fN9tvXzfrjtgnayLlRocXOdVpD64ztWoPkVlDTGsJO95ZCb1bGohOyl1WBdQFEpxGwN5JQnbEPD76HpRupD3QMNPhDjjXyvU8Y_b-bKf7yN-nOW7lyIFU1ePtokNPvhcrsx1gCDQNOlJbipdFWC23AVfTNf-g-LXmq5x0pp5xptajUuwcq5FRKpt3fMAL88Xf-ye_UH5XyiiQ</recordid><startdate>20210628</startdate><enddate>20210628</enddate><creator>Yamamoto, Akitaka</creator><creator>Wada, Hideo</creator><creator>Ichkawa, Yuhuko</creator><creator>Tanaka, Motoko</creator><creator>Tashiro, Haruhiko</creator><creator>Shiraki, Katsuya</creator><creator>Shimpo, Hideto</creator><creator>Yamashita, Yoshiki</creator><creator>Mastumoto, Takeshi</creator><creator>Shimaoka, Motomu</creator><creator>Iba, Toshiaki</creator><creator>Suzuki-Inoue, Katsue</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9021-8633</orcidid><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid></search><sort><creationdate>20210628</creationdate><title>Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation</title><author>Yamamoto, Akitaka ; Wada, Hideo ; Ichkawa, Yuhuko ; Tanaka, Motoko ; Tashiro, Haruhiko ; Shiraki, Katsuya ; Shimpo, Hideto ; Yamashita, Yoshiki ; Mastumoto, Takeshi ; Shimaoka, Motomu ; Iba, Toshiaki ; Suzuki-Inoue, Katsue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute coronary syndromes</topic><topic>Aortic aneurysms</topic><topic>Biomarkers</topic><topic>Blood platelets</topic><topic>Cancer therapies</topic><topic>Clinical medicine</topic><topic>Disease</topic><topic>Hypothermia</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Monoclonal antibodies</topic><topic>Obstetrics</topic><topic>Patients</topic><topic>Plasma</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Akitaka</creatorcontrib><creatorcontrib>Wada, Hideo</creatorcontrib><creatorcontrib>Ichkawa, Yuhuko</creatorcontrib><creatorcontrib>Tanaka, Motoko</creatorcontrib><creatorcontrib>Tashiro, Haruhiko</creatorcontrib><creatorcontrib>Shiraki, Katsuya</creatorcontrib><creatorcontrib>Shimpo, Hideto</creatorcontrib><creatorcontrib>Yamashita, Yoshiki</creatorcontrib><creatorcontrib>Mastumoto, Takeshi</creatorcontrib><creatorcontrib>Shimaoka, Motomu</creatorcontrib><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Suzuki-Inoue, Katsue</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Akitaka</au><au>Wada, Hideo</au><au>Ichkawa, Yuhuko</au><au>Tanaka, Motoko</au><au>Tashiro, Haruhiko</au><au>Shiraki, Katsuya</au><au>Shimpo, Hideto</au><au>Yamashita, Yoshiki</au><au>Mastumoto, Takeshi</au><au>Shimaoka, Motomu</au><au>Iba, Toshiaki</au><au>Suzuki-Inoue, Katsue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation</atitle><jtitle>Journal of clinical medicine</jtitle><date>2021-06-28</date><risdate>2021</risdate><volume>10</volume><issue>13</issue><spage>2860</spage><pages>2860-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC in critically ill patients. Plasma levels of sCLEC-2 and D-dimer were measured using the STACIA system. Plasma sCLEC-2 and D-dimer levels were significantly higher in patients with underlying diseases of DIC than in those with unidentified clinical syndrome (UCS). Plasma sCLEC-2 levels were significantly higher in the patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. Similarly, plasma D-dimer levels were also significantly higher in patients with DIC and Pre-DIC than in those without DIC or Pre-DIC. The plasma sCLEC-2 levels in all patients and those with a DIC score ≤ 4 were significantly higher in non-survivors than survivors. The plasma D-dimer levels in all patients, those with a DIC score ≥ 5 and those with a DIC score ≤ 4, were significantly higher in non-survivors than in survivors. The plasma sCLEC-2 is expected as a marker for DIC/Pre-DIC as well as the prognostic marker in critically ill patients.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34203210</pmid><doi>10.3390/jcm10132860</doi><orcidid>https://orcid.org/0000-0001-9021-8633</orcidid><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2021-06, Vol.10 (13), p.2860
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8269023
source PubMed (Medline); Publicly Available Content Database
subjects Acute coronary syndromes
Aortic aneurysms
Biomarkers
Blood platelets
Cancer therapies
Clinical medicine
Disease
Hypothermia
Infections
Laboratories
Monoclonal antibodies
Obstetrics
Patients
Plasma
Thrombosis
title Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T22%3A01%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20C-Type%20Lectin-Like%20Receptor%202%20Is%20a%20Biomarker%20for%20Disseminated%20Intravascular%20Coagulation&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Yamamoto,%20Akitaka&rft.date=2021-06-28&rft.volume=10&rft.issue=13&rft.spage=2860&rft.pages=2860-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10132860&rft_dat=%3Cproquest_pubme%3E2549395741%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c452t-3c7ab9b4407958b75ae9604215eab4d8ecd5658a912d2565089c01b4a0ad52ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2549395741&rft_id=info:pmid/34203210&rfr_iscdi=true